DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Akpentolate is a drug marketed by Akorn and is included in two NDAs.
The generic ingredient in AKPENTOLATE is cyclopentolate hydrochloride. There are two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cyclopentolate hydrochloride profile page.
A generic version of AKPENTOLATE was approved as cyclopentolate hydrochloride by AKORN INC on December 9th, 2015.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Akorn||AKPENTOLATE||cyclopentolate hydrochloride||SOLUTION/DROPS;OPHTHALMIC||040164-001||Jan 13, 1997||AT||RX||No||No||Start Trial||Start Trial||Start Trial|
|Akorn||AKPENTOLATE||cyclopentolate hydrochloride||SOLUTION/DROPS;OPHTHALMIC||040165-001||Jan 13, 1997||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|